£54.00

It has never been this cheap. We have no record of a lower price.

£54 today · cheaper than every other day in the last 3 months

LAP Lambert Academic Publishing TNF: A promissing Immunomodulatory therapeutic Agent for tuberculosis: Tuberculosis and Tumour Necrosis Factor: Way for Immunomodulatory TB Therapy

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£54.00 £51.30 £52.38 £53.46 £54.54 £55.62 £56.70 22 August 2026 27 August 2026 02 September 2026 08 September 2026 14 September 2026
View at Amazon ↗

Price data last checked 67 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £54 Days at Price

Price Analysis

Most common price: £54 (24 days, 100.0%)

Price range: £54 - £54

Price levels: 1 different prices over 24 days

Description

Despite the decline observed in tuberculosis (TB) rates, globally, TB still the leading cause of death from infectious diseases. Current TB drugs are unable to fully eradicate Mycobacterium tuberculosis at all sites of infection because of their relative inactivity against persisting organisms, mainly those in granulomas. Granulomas contain mycobacteria by recruitment of immune cells that surround the bacilli. When granulomas fail to contain bacilli, the phenomenon leads in the development of progressive primary TB disease or reactivation of latent TB; whereby bacilli may disseminate to other organs and cause extrapulmonary TB (e.g.central nervous system TB). Central nervous system tuberculosis is the most severe form of extrapulmonary tuberculosis, characterised by the formation of rich foci a brain form of granulomas, and tuberculous meningitis. The cytokine tumour necrosis factor (TNF) is involved in the recruitment of the immune cells and structure maintenance of granulomas. The book demonstrates the role of TNF from different cell-type during tuberculosis. Suggesting how cell-type specific targeted cytokine TB therapy may integrate into the clinica arena.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 January 2016
Listed Since
11 February 2016

Barcode

No barcode data available

Similar Products You Might Like

The New Paradigm of Immunity to Tuberculosis: 783 (Advances in Experimental Medicine and Biology, 783)
81% match

The New Paradigm of Immunity to Tuberculosis: 783 (Advances in Experimental Medicine and Biology, 783)

Springer

£111.08 22 Oct 2026
Tuberculosis Host-Pathogen Interactions
79% match

Tuberculosis Host-Pathogen Interactions

Springer

£106.78 16 Nov 2026
Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions
79% match

Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions

Springer

£107.47 14 Sep 2026
Tuberculosis and Nontuberculosis Mycobacterial Infections
79% match

Tuberculosis and Nontuberculosis Mycobacterial Infections

McGraw-Hill Education

£63.99 24 Oct 2026
Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management (Respiratory Medicine)
78% match

Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management (Respiratory Medicine)

Humana

£117.77 29 Oct 2026
Therapeutic Targets of the TNF Superfamily: 647 (Advances in Experimental Medicine and Biology, 647)
78% match

Therapeutic Targets of the TNF Superfamily: 647 (Advances in Experimental Medicine and Biology, 647)

Springer

£110.46 26 Oct 2026
Tuberculosis in Clinical Practice
78% match

Tuberculosis in Clinical Practice

Springer

£104.34 15 Sep 2026
UROGENITAL TUBERCULOSIS OVERVIEW AND MANAGEMENT: ANTI-TUBERCULAR DRUGS AND DRUG RESISTANCE
78% match

UROGENITAL TUBERCULOSIS OVERVIEW AND MANAGEMENT: ANTI-TUBERCULAR DRUGS AND DRUG RESISTANCE

LAP Lambert Academic Publishing

£62.00 10 Sep 2026
Tuberculosis of the Gastrointestinal system
77% match

Tuberculosis of the Gastrointestinal system

Springer

£87.45 16 Nov 2026
Inflammation
77% match

Inflammation

Springer

£123.72 22 Oct 2026
Inflammation
77% match

Inflammation

Springer

£124.36 12 Sep 2026
Tuberculosis Host-Pathogen Interactions
77% match

Tuberculosis Host-Pathogen Interactions

Springer

£107.03 08 Sep 2026
Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)
77% match

Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)

Springer

£76.42 27 Oct 2026
Molecular characterization of Zoonotic Mycobacterium: Polymersase chain reaction for molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis
77% match

Molecular characterization of Zoonotic Mycobacterium: Polymersase chain reaction for molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis

LAP Lambert Academic Publishing

£43.00 14 Sep 2026
New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis
77% match

New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis

LAP Lambert Academic Publishing

£68.00 06 Nov 2026
Mycobacteria: Molecular Biology and Virulence
76% match

Mycobacteria: Molecular Biology and Virulence

Wiley

£239.47 27 Oct 2026
Туберкулез у детей из семейного очага инфекции
76% match

Туберкулез у детей из семейного очага инфекции

LAP Lambert Academic Publishing

£67.00 11 Nov 2026
Neurobrucellosis: Clinical, Diagnostic and Therapeutic Features
76% match

Neurobrucellosis: Clinical, Diagnostic and Therapeutic Features

Springer

£88.21 26 Oct 2026
Mycobacterium Tuberculosis Protocols: 54 (Methods in Molecular Medicine, 54)
76% match

Mycobacterium Tuberculosis Protocols: 54 (Methods in Molecular Medicine, 54)

Humana

£80.67 23 Oct 2026
Manual of counseling in tuberculosis: principles and practical study
76% match

Manual of counseling in tuberculosis: principles and practical study

LAP Lambert Academic Publishing

£55.00 09 Nov 2026
Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)
76% match

Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)

Springer

£110.63 21 Oct 2026
Isolation and Molecular Characterization of Mycobacterium Bovis: Isolation and Molecular Characterization of M.Bovis from Cattle Slaughtered at Hawassa University and Municipal Abattoir
75% match

Isolation and Molecular Characterization of Mycobacterium Bovis: Isolation and Molecular Characterization of M.Bovis from Cattle Slaughtered at Hawassa University and Municipal Abattoir

LAP Lambert Academic Publishing

£42.00 12 Nov 2026
Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses
75% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Elsevier

£137.99 21 Oct 2026
Immunopharmacology of Neutrophils (Handbook of Immunopharmacology)
75% match

Immunopharmacology of Neutrophils (Handbook of Immunopharmacology)

Elsevier

£95.00 03 Nov 2026